Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Teladoc Health, Inc.TDOC · Entity 1547 | President, U.S. Group Health | September 01, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Teladoc Health, Inc.
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 92,832 |
Ending reported balance
After 2026-09-02 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-09-01 · Exercise / conversion · Acquired 4,859 · Balance 89,737 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 2 · 2026-09-01 · Exercise / conversion · Acquired 9,152 · Balance 98,889 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 3 · 2026-09-01 · Exercise / conversion · Acquired 1,300 · Balance 100,189 F2: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Row 4 · 2026-09-02 · Sale · Disposed 7,357 · Balance 92,832 F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 9,718 |
Reported balance
After 2026-09-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-01 · Exercise / conversion · Disposed 4,859 · Balance 9,718 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4: On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 54,918 |
Reported balance
After 2026-09-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-01 · Exercise / conversion · Disposed 9,152 · Balance 54,918 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5: On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 7,798 |
Reported balance
After 2026-09-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-01 · Exercise / conversion · Disposed 1,300 · Balance 7,798 F2: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F6: On March 1, 2026, the reporting person earned 15,596 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4: On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
F5: On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6: On March 1, 2026, the reporting person earned 15,596 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 02, 2026 Filed Sep 3, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 7,357 | $6.30 | $46,356.46 |
DisclosureSEC source: 0002036989-26-000014 · wk-form4_1788465944.xml · nonDerivative · entry 4 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,832 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,300 | $0.00 | $0.00 |
DisclosureSEC source: 0002036989-26-000014 · wk-form4_1788465944.xml · derivative · entry 7 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,798 Underlying: Common Stock · 1,300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 1, 2026, the reporting person earned 15,596 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F6 · derivative.expiration_date: On March 1, 2026, the reporting person earned 15,596 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 9,152 | $0.00 | $0.00 |
DisclosureSEC source: 0002036989-26-000014 · wk-form4_1788465944.xml · derivative · entry 6 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,918 Underlying: Common Stock · 9,152 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 4,859 | $0.00 | $0.00 |
DisclosureSEC source: 0002036989-26-000014 · wk-form4_1788465944.xml · derivative · entry 5 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,718 Underlying: Common Stock · 4,859 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. F4 · derivative.expiration_date: On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,300 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002036989-26-000014 · wk-form4_1788465944.xml · nonDerivative · entry 3 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,189 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 9,152 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002036989-26-000014 · wk-form4_1788465944.xml · nonDerivative · entry 2 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,889 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,859 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002036989-26-000014 · wk-form4_1788465944.xml · nonDerivative · entry 1 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,737 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| July 06, 2026 Filed Jul 6, 2026 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,500 | $9.50 | $23,750.00 |
DisclosureSEC source: 0002036989-26-000012 · wk-form4_1783368325.xml · nonDerivative · entry 1 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 84,878 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on August 14, 2025. Read SEC document |
| July 01, 2026 Filed Jul 1, 2026 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,500 | $9.00 | $22,500.00 |
DisclosureSEC source: 0002036989-26-000010 · wk-form4_1782940603.xml · nonDerivative · entry 1 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 87,378 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on August 14, 2025. Read SEC document |
| June 29, 2026 Filed Jun 30, 2026 21:45 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,500 | $8.50 | $21,250.00 |
DisclosureSEC source: 0002036989-26-000008 · wk-form4_1782855947.xml · nonDerivative · entry 1 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,878 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on August 14, 2025. Read SEC document |
| June 02, 2026 Filed Jun 3, 2026 20:24 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 7,679 | $7.63 | $58,567.73 |
DisclosureSEC source: 0002036989-26-000006 · wk-form4_1780518288.xml · nonDerivative · entry 4 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,378 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:24 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 9,152 | $0.00 | $0.00 |
DisclosureSEC source: 0002036989-26-000006 · wk-form4_1780518288.xml · derivative · entry 7 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,070 Underlying: Common Stock · 9,152 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F6 · derivative.expiration_date: On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:24 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 4,858 | $0.00 | $0.00 |
DisclosureSEC source: 0002036989-26-000006 · wk-form4_1780518288.xml · derivative · entry 6 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,577 Underlying: Common Stock · 4,858 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. F5 · derivative.expiration_date: On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:24 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,300 | $0.00 | $0.00 |
DisclosureSEC source: 0002036989-26-000006 · wk-form4_1780518288.xml · derivative · entry 5 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,098 Underlying: Common Stock · 1,300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 1, 2026, the reporting person earned 15,596 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On March 1, 2026, the reporting person earned 15,596 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:24 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 9,152 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002036989-26-000006 · wk-form4_1780518288.xml · nonDerivative · entry 3 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:24 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,858 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002036989-26-000006 · wk-form4_1780518288.xml · nonDerivative · entry 2 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,905 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:24 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,300 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002036989-26-000006 · wk-form4_1780518288.xml · nonDerivative · entry 1 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,047 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 26,647 | $5.12 | $136,352.70 |
DisclosureSEC source: 0002036989-26-000002 · wk-form4_1772572111.xml · nonDerivative · entry 6 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,747 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 181,661 | $0.00 | $0.00 |
DisclosureSEC source: 0002036989-26-000002 · wk-form4_1772572111.xml · derivative · entry 13 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,661 Underlying: Common Stock · 181,661 shares Expires not disclosed F12 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F13 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F13 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 5,198 | $0.00 | $0.00 |
DisclosureSEC source: 0002036989-26-000002 · wk-form4_1772572111.xml · derivative · entry 12 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,260 Underlying: Common Stock · 5,198 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F11 · derivative.exercise_date: On March 1, 2026, the reporting person earned 27,458 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F11 · derivative.expiration_date: On March 1, 2026, the reporting person earned 27,458 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 27,458 | $0.00 | $0.00 |
DisclosureSEC source: 0002036989-26-000002 · wk-form4_1772572111.xml · derivative · entry 11 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,458 Underlying: Common Stock · 27,458 shares Expires not disclosed F8 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F9 · shares: Performance award amount determined based on metrics in respect of the issuer's 2025 financial results. F10 · derivative.exercise_date: The performance stock units vest as to one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F10 · derivative.expiration_date: The performance stock units vest as to one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,186 | $0.00 | $0.00 |
DisclosureSEC source: 0002036989-26-000002 · wk-form4_1772572111.xml · derivative · entry 10 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,186 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F7 · derivative.exercise_date: On March 1, 2024, the reporting person earned 14,263 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F7 · derivative.expiration_date: On March 1, 2024, the reporting person earned 14,263 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 36,610 | $0.00 | $0.00 |
DisclosureSEC source: 0002036989-26-000002 · wk-form4_1772572111.xml · derivative · entry 9 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,222 Underlying: Common Stock · 36,610 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F6 · derivative.expiration_date: On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 4,858 | $0.00 | $0.00 |
DisclosureSEC source: 0002036989-26-000002 · wk-form4_1772572111.xml · derivative · entry 8 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,435 Underlying: Common Stock · 4,858 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. F5 · derivative.expiration_date: On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 3,488 | $0.00 | $0.00 |
DisclosureSEC source: 0002036989-26-000002 · wk-form4_1772572111.xml · derivative · entry 7 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,488 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 41,853 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 41,853 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 5,198 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002036989-26-000002 · wk-form4_1772572111.xml · nonDerivative · entry 5 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,394 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,186 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002036989-26-000002 · wk-form4_1772572111.xml · nonDerivative · entry 4 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,196 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 36,610 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002036989-26-000002 · wk-form4_1772572111.xml · nonDerivative · entry 3 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,010 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,858 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002036989-26-000002 · wk-form4_1772572111.xml · nonDerivative · entry 2 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,488 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002036989-26-000002 · wk-form4_1772572111.xml · nonDerivative · entry 1 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 27, 2026 Filed Mar 12, 2026 20:06 UTC Amendment | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 5,198 | $0.00 | $0.00 |
DisclosureSEC source: 0002036989-26-000004 · wk-form4a_1773345998.xml · derivative · entry 2 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,398 Underlying: Common Stock · 5,198 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 1, 2026, the reporting person earned 15,596 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F6 · derivative.expiration_date: On March 1, 2026, the reporting person earned 15,596 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · balance_after: The Form 4 filed March 3, 2026, inadvertently included an incorrect amount for the number of performance stock units awarded. This amendment reports the correct amount. Read SEC document |
| February 27, 2026 Filed Mar 12, 2026 20:06 UTC Amendment | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 15,596 | $0.00 | $0.00 |
DisclosureSEC source: 0002036989-26-000004 · wk-form4a_1773345998.xml · derivative · entry 1 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,596 Underlying: Common Stock · 15,596 shares Expires not disclosed F1 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F2 · shares: Performance award amount determined based on metrics in respect of the issuer's 2025 financial results. F3 · derivative.exercise_date: The performance stock units vest as to one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: The performance stock units vest as to one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · balance_after: The Form 4 filed March 3, 2026, inadvertently included an incorrect amount for the number of performance stock units awarded. This amendment reports the correct amount. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 02:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 4,582 | $7.49 | $34,310.02 |
DisclosureSEC source: 0002036989-25-000003 · wk-form4_1764813793.xml · nonDerivative · entry 4 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,054 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 02:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 4,858 | $0.00 | $0.00 |
DisclosureSEC source: 0002036989-25-000003 · wk-form4_1764813793.xml · derivative · entry 7 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,293 Underlying: Common Stock · 4,858 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. F6 · derivative.expiration_date: On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 02:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 3,488 | $0.00 | $0.00 |
DisclosureSEC source: 0002036989-25-000003 · wk-form4_1764813793.xml · derivative · entry 6 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,488 Underlying: Common Stock · 3,488 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 41,853 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 41,853 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 02:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,189 | $0.00 | $0.00 |
DisclosureSEC source: 0002036989-25-000003 · wk-form4_1764813793.xml · derivative · entry 5 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,186 Underlying: Common Stock · 1,189 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 1, 2024, the reporting person earned 14,263 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On March 1, 2024, the reporting person earned 14,263 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 02:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,858 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002036989-25-000003 · wk-form4_1764813793.xml · nonDerivative · entry 3 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,636 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 02:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,488 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002036989-25-000003 · wk-form4_1764813793.xml · nonDerivative · entry 2 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,778 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 02:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,189 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002036989-25-000003 · wk-form4_1764813793.xml · nonDerivative · entry 1 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| September 02, 2025 Filed Sep 3, 2025 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 4,700 | $7.59 | $35,649.50 |
DisclosureSEC source: 0001477449-25-000106 · wk-form4_1756929924.xml · nonDerivative · entry 4 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,101 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| August 29, 2025 Filed Sep 3, 2025 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 4,858 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000106 · wk-form4_1756929924.xml · derivative · entry 7 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,151 Underlying: Common Stock · 4,858 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. F6 · derivative.expiration_date: On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. Read SEC document |
| August 29, 2025 Filed Sep 3, 2025 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 3,488 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000106 · wk-form4_1756929924.xml · derivative · entry 6 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,976 Underlying: Common Stock · 3,488 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 41,853 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 41,853 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| August 29, 2025 Filed Sep 3, 2025 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000106 · wk-form4_1756929924.xml · derivative · entry 5 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,375 Underlying: Common Stock · 1,189 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 1, 2024, the reporting person earned 14,263 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On March 1, 2024, the reporting person earned 14,263 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| August 29, 2025 Filed Sep 3, 2025 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,858 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-25-000106 · wk-form4_1756929924.xml · nonDerivative · entry 3 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,801 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| August 29, 2025 Filed Sep 3, 2025 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,488 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-25-000106 · wk-form4_1756929924.xml · nonDerivative · entry 2 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,943 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| August 29, 2025 Filed Sep 3, 2025 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,189 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-25-000106 · wk-form4_1756929924.xml · nonDerivative · entry 1 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| June 02, 2025 Filed Jun 3, 2025 21:36 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 4,653 | $6.86 | $31,919.58 |
DisclosureSEC source: 0001477449-25-000082 · wk-form4_1748986606.xml · nonDerivative · entry 4 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,266 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 21:36 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 4,858 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000082 · wk-form4_1748986606.xml · derivative · entry 7 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,009 Underlying: Common Stock · 4,858 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. F6 · derivative.expiration_date: On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 21:36 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 3,488 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000082 · wk-form4_1748986606.xml · derivative · entry 6 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,464 Underlying: Common Stock · 3,488 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 41,853 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 41,853 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 21:36 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000082 · wk-form4_1748986606.xml · derivative · entry 5 Bliss Kelly · CIK 0002036989 · President, U.S. Group Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,564 Underlying: Common Stock · 1,189 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 1, 2024, the reporting person earned 14,263 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On March 1, 2024, the reporting person earned 14,263 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.